327 related articles for article (PubMed ID: 10822329)
1. Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
Liuzzi GM; Mastroianni CM; Santacroce MP; Fanelli M; D'Agostino C; Vullo V; Riccio P
J Neurovirol; 2000 Apr; 6(2):156-63. PubMed ID: 10822329
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.
Christo PP; Greco DB; Aleixo AW; Livramento JA
BMC Infect Dis; 2007 Dec; 7():147. PubMed ID: 18096083
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid levels of chemokines in HIV infected patients with and without opportunistic infection of the central nervous system.
Christo PP; Vilela Mde C; Bretas TL; Domingues RB; Greco DB; Livramento JA; Teixeira AL
J Neurol Sci; 2009 Dec; 287(1-2):79-83. PubMed ID: 19782379
[TBL] [Abstract][Full Text] [Related]
4. Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis.
Matsuura E; Umehara F; Hashiguchi T; Fujimoto N; Okada Y; Osame M
J Neurol Sci; 2000 Feb; 173(1):45-52. PubMed ID: 10675579
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system.
Gallo P; Sivieri S; Rinaldi L; Yan XB; Lolli F; De Rossi A; Tavolato B
J Neurol Sci; 1994 Oct; 126(1):49-53. PubMed ID: 7836946
[TBL] [Abstract][Full Text] [Related]
6. Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis.
Lee KY; Kim EH; Yang WS; Ryu H; Cho SN; Lee BI; Heo JH
J Neurol Sci; 2004 May; 220(1-2):73-8. PubMed ID: 15140609
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels.
Martin C; Albert J; Hansson P; Pehrsson P; Link H; Sönnerborg A
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):214-9. PubMed ID: 9495220
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.
Leppert D; Leib SL; Grygar C; Miller KM; Schaad UB; Holländer GA
Clin Infect Dis; 2000 Jul; 31(1):80-4. PubMed ID: 10913401
[TBL] [Abstract][Full Text] [Related]
9. Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo.
Price NM; Farrar J; Tran TT; Nguyen TH; Tran TH; Friedland JS
J Immunol; 2001 Mar; 166(6):4223-30. PubMed ID: 11238675
[TBL] [Abstract][Full Text] [Related]
10. Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients.
Sporer B; Paul R; Koedel U; Grimm R; Wick M; Goebel FD; Pfister HW
J Infect Dis; 1998 Sep; 178(3):854-7. PubMed ID: 9728558
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia.
Conant K; McArthur JC; Griffin DE; Sjulson L; Wahl LM; Irani DN
Ann Neurol; 1999 Sep; 46(3):391-8. PubMed ID: 10482270
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid tau concentrations in HIV infected patients with suspected neurological disease.
Green AJ; Giovannoni G; Hall-Craggs MA; Thompson EJ; Miller RF
Sex Transm Infect; 2000 Dec; 76(6):443-6. PubMed ID: 11221126
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count.
Yushchenko M; Weber F; Mäder M; Schöll U; Maliszewska M; Tumani H; Felgenhauer K; Beuche W
J Neuroimmunol; 2000 Oct; 110(1-2):244-51. PubMed ID: 11024556
[TBL] [Abstract][Full Text] [Related]
14. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury.
Rosenberg GA; Dencoff JE; Correa N; Reiners M; Ford CC
Neurology; 1996 Jun; 46(6):1626-32. PubMed ID: 8649561
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis.
Liuzzi GM; Trojano M; Fanelli M; Avolio C; Fasano A; Livrea P; Riccio P
Mult Scler; 2002 May; 8(3):222-8. PubMed ID: 12120694
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis.
Beuche W; Yushchenko M; Mäder M; Maliszewska M; Felgenhauer K; Weber F
Neuroreport; 2000 Nov; 11(16):3419-22. PubMed ID: 11095490
[TBL] [Abstract][Full Text] [Related]
17. MMPs/TIMPs imbalances in the peripheral blood and cerebrospinal fluid are associated with the pathogenesis of HIV-1-associated neurocognitive disorders.
Xing Y; Shepherd N; Lan J; Li W; Rane S; Gupta SK; Zhang S; Dong J; Yu Q
Brain Behav Immun; 2017 Oct; 65():161-172. PubMed ID: 28487203
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement.
Trysberg E; Blennow K; Zachrisson O; Tarkowski A
Arthritis Res Ther; 2004; 6(6):R551-6. PubMed ID: 15535833
[TBL] [Abstract][Full Text] [Related]
19. High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis.
Morris L; Silber E; Sonnenberg P; Eintracht S; Nyoka S; Lyons SF; Saffer D; Koornhof H; Martin DJ
J Infect Dis; 1998 Feb; 177(2):473-6. PubMed ID: 9466541
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid concentration of fibronectin in patients with HIV-1 infection and central nervous system disorders.
Torre D; Zeroli C; Ferrario G; Bonetta G; Fiori GP; Martegani R
J Clin Pathol; 1993 Nov; 46(11):1039-41. PubMed ID: 8254093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
